✦ LIBER ✦

HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study

✍ Scribed by Isabelle Ray-Coquard; Jean Paul Guastalla; Djelila Allouache; Martin Combe; Béatrice Weber; J. Cretin; Hervé Curé; S. Nunhuck; Désiré Paraiso; Mireille Mousseau; Eric Pujade-Lauraine

Book ID: 119936362
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 103 KB
Volume: 1
Category: Article
ISSN: 1941-4390
DOI: 10.3816/coc.2008.n.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination docetaxel and trastuzumab tr

Combination docetaxel and trastuzumab treatment for patients with her-2-overexpressing metastatic breast cancer: A multicenter, phase-II study

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Topotecan and paclitaxel in second line

Topotecan and paclitaxel in second line treatment of advanced ovarian cancer (AOC): a gineco phase II trial

✍ Fabbro, M.; Leduc, B.; Mignot, L.; Ayela, P.; Assouline, D.; Gouttebel, M.C.; Le 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Phase II study of preoperative systemic

Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer

✍ Masataka Sawaki; Hiroji Iwata; Yasuyuki Sato; Masaki Wada; Tatsuya Toyama; Eiich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 635 KB

A multicenter phase II study of cisplati

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

✍ Véronique Diéras; JeanPaul Guastalla; JeanMarc Ferrero; Hervé Curé; Béatrice Web 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Topotecan (T) and cyclophosphamide (CY)

Topotecan (T) and cyclophosphamide (CY) in second line treatment of advanced ovarian cancer (AOC): a gineco phase II trial

✍ Mayer, F.; Peaud, P.Y.; Tigaud, J.D.; Kaminsky, M.C.; Culine, S.; Walter, S.; Ba 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB